Japan Insulin Infusion Pump Market Size
| Study Period | 2019 - 2029 |
| Base Year For Estimation | 2023 |
| Forecast Data Period | 2024 - 2029 |
| Historical Data Period | 2019 - 2022 |
| CAGR | 4.10 % |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Japan Insulin Infusion Pump Market Analysis
Japan Insulin Infusion Pumps Market is expected to register a CAGR of more than 4.1% and reach a value of about USD 65.72 million over the forecast period.
The number of Japanese casualties of the COVID-19 pandemic was lower than that of other countries, which might be attributed to genetic variances, aspects of Japanese culture, and differences in the coagulation system between Japanese and Caucasians. In order to alleviate hospital overcrowding, the Osaka Prefectural Government classified patients as mild, moderate, or severe and assigned them to different alternative lodgings. In compliance with national government rules, hospitals offer patient care. Individuals with intermediate conditions, or those with adequate oxygen saturation readings despite the presence of symptoms on computed tomography, are being targeted. In contrast to Type 1 diabetes, which is caused by immune system failure, Type 2 diabetes is connected to a sedentary lifestyle, which promotes the development of intrinsic insulin resistance.
Japan's aging population, which is more vulnerable to illness, as well as an increase in obesity caused by inactivity and irregular eating patterns, are thought to be contributing causes to the country's growing diabetes incidence. More people have been diagnosed with the condition as a result of being sent to a medical institution based on the findings of the metabolic syndrome screening, which was established in 2008 to avoid lifestyle-related ailments. Diabetes incidence in Japan is expected to rise much further as the population ages. The number of Japanese individuals with type 1 diabetes is estimated to be 100,000-140,000, accounting for 0.09-0.1% of the total population. The number of insulin pump users among Japanese patients with type 1 diabetes mellitus is believed to be around 10,000, implying that the insulin pump has not yet overrun Japan.
Japan Insulin Infusion Pump Market Trends
Insulin Pump is Expected to Witness Growth Over the Forecast Period
An insulin pump is a device that delivers insulin on a continuous or as-needed basis. The pump is based on the human pancreas. The insulin infusion pump can be used in place of the traditional daily injection routine or an insulin pen. Insulin pump therapy is a popular insulin administration method for persons with type 1 diabetes (T1DM). Pumps are a well-known, time-tested therapy option for T1DM patients of all ages, delivering near-physiological insulin delivery when the pancreas fails to produce insulin. Pumps with remote controls allow parents to suspend or bolus insulin from a distance while their child is playing or eating.
When compared to injections, insulin infusion pumps prevent big fluctuations in blood glucose levels, cause less discomfort, and dispense more precisely. The benefits of insulin pumps over traditional delivery systems are projected to drive market growth. Continuous subcutaneous insulin infusion (CSII, also known as insulin pumps) and continuous glucose monitoring systems (CGMs) have significantly improved patient care and quality of life and are commonly utilized in the ambulatory context. This technology is increasingly being employed in the healthcare setting. Because of the rising obesity incidence, increasing hereditary risks for type 2 diabetes, and an increasing number of Type 1 diabetes patients, the insulin infusion pump industry is expected to expand further.
Rising diabetes prevalence
An article published titled "Current trends in diabetes mellitus database research in Japan," funded by AstraZeneca and Ono Pharmaceutical Co., Ltd., stated that East Asians tend to develop type 2 diabetes mellitus with a lower mean BMI compared to Caucasians while also having a greater amount of body fat with a tendency of visceral adiposity at any BMI. Diabetes occurs at a younger age in Japanese patients and is characterized by early-cell dysfunction, as well as insulin resistance due to increased visceral adiposity. According to the article "Dietary Patterns and New-Onset Type 2 Diabetes Mellitus in Evacuees after the Great East Japan Earthquake: A 7-Year Longitudinal Analysis in the Fukushima Health Management Survey", published in 2022, there is evidence of associations between dietary behaviors or diet quality indices, food groups, single foods, and beverages, specific macronutrients and micronutrients, and the incidence of type 2 diabetes mellitus in Japan. Dietary habits are thought to play a role in the development or prevention of type 2 diabetes mellitus.
A Westernized diet is the main reason Japanese individuals are more likely to acquire type 2 diabetes. Traditional Japanese food has a low fat and calorie content, but a shift in people's desire for processed food, particularly food rich in animal fat and calories, has been linked to increased abdominal adiposity, which can lead to type 2 diabetes. Despite the importance of public awareness and education on diabetes, there is a shortage of standard diabetes education support tools for persons with diabetes in Japan. A lack of time and passion among the population, as well as sickness stigma, are some additional impediments. While diabetes screening tests are performed on a regular basis in Japan, there is still a lack of methods for treating them soon after the screening, resulting in the loss of the essential phase of therapy and the development of complications, and this impacts the growth of the usage of insulin pump in the forecast period.
Japan Insulin Infusion Pump Industry Overview
Due to the existence of only a few big businesses operating internationally and locally, the insulin infusion pump industry is concentrated. The competitive landscape includes an examination of a few well-known worldwide and local organizations, such as Medtronic PLC, Insulet Corporation, Ypsomed, Ascensia Diabetes Care, and Tandem Diabetes Care.
Japan Insulin Infusion Pump Market Leaders
-
Medtronics
-
Ascensia Diabetes Care
-
Insulet Corporation
-
Tandem Diabetes Care
-
Ypsomped
*Disclaimer: Major Players sorted in no particular order
Japan Insulin Infusion Pump Market News
- May 2023: Medtronic acquires insulin patch pump maker EOFlow for USD 738M amid new MiniMed rollout.
- May 2023: Tandem plots late 2023 launch of a slimmed-down insulin pump with Dexcom and Abbott CGM integrations.
Table of Contents
1. INTRODUCTION
- 1.1 Study Assumptions and Market Definition
- 1.2 Scope of the Study
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
- 4.1 Market Overview
- 4.2 Market Drivers
- 4.3 Market Restraints
-
4.4 Porter's Five Forces Analysis
- 4.4.1 Bargaining Power of Suppliers
- 4.4.2 Bargaining Power of Consumers
- 4.4.3 Threat of New Entrants
- 4.4.4 Threat of Substitute Products and Services
- 4.4.5 Intensity of Competitive Rivalry
5. MARKET SEGMENTATION
-
5.1 Insulin Infusion Pump
- 5.1.1 Insulin Pump Device
- 5.1.2 Infusion Set
- 5.1.3 Reservoir
6. MARKET INDICATORS
- 6.1 Type-1 Diabetic Population
- 6.2 Type-2 Diabetic Population
7. COMPETITIVE LANDSCAPE
-
7.1 COMPANY PROFILES
- 7.1.1 Medtronic
- 7.1.2 Insulet corporation
- 7.1.3 Ypsomed
- 7.1.4 Tandem Diabetes Care
- 7.1.5 Ascensia Diabetes Care
- *List Not Exhaustive
- 7.2 COMPANY SHARE ANALYSIS
8. MARKET OPPORTUNITIES AND FUTURE TRENDS
** Subject To AvailablityJapan Insulin Infusion Pump Industry Segmentation
An insulin pump is used to deliver insulin to achieve proper blood sugar control and minimize hypoglycemia's effects. The pump is composed of a pump reservoir like an insulin cartridge, a battery-operated pump, and a computer chip that allows the user to control the exact amount of insulin being delivered. The pump is attached to a thin plastic tube (an infusion set) with a soft cannula (or needle) at the end through which insulin passes. Japan's insulin infusion pumps market is segmented by component (pump device, infusion set, and reservoir). The report offers the value (in USD million) and Volume (in units Million) for the above segments.
| Insulin Infusion Pump | Insulin Pump Device |
| Infusion Set | |
| Reservoir |
Frequently Asked Questions
What is the current Japan Insulin Infusion Pump Market size?
The Japan Insulin Infusion Pump Market is projected to register a CAGR of greater than 4.10% during the forecast period (2024-2029)
Who are the key players in Japan Insulin Infusion Pump Market?
Medtronics, Ascensia Diabetes Care, Insulet Corporation, Tandem Diabetes Care and Ypsomped are the major companies operating in the Japan Insulin Infusion Pump Market.
What years does this Japan Insulin Infusion Pump Market cover?
The report covers the Japan Insulin Infusion Pump Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Japan Insulin Infusion Pump Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029.
Japan Insulin Infusion Pump Industry Report
Statistics for the 2024 Japan Insulin Infusion Pump market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Japan Insulin Infusion Pump analysis includes a market forecast outlook to for 2024 to 2029 and historical overview. Get a sample of this industry analysis as a free report PDF download.
